Depletion of CD4 T-cells and macrophages reduced combination anti-PD-1/CTLA4 (Fc-effector)-mediated colitis (figure 2B–D) and inflammation of the small intestine (online supplemental figure 2). This evidence concerns the gene PDCD1 and colitis.